Dr. Resham Khilnani, MD

Dr. Khilnani practices at Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation.

Dr. Khilnani's NPI, 1013952423, was assigned on June 19, 2006. Dr. Khilnani graduated from Krishna Institute Of Medical Sciences University in 2000. Dr. Khilnani holds Florida license ME98786.

Dr. Khilnani's primary practice is Cleveland Clinic Martin North Hospital, at 200 SE Hospital Ave, Stuart, FL 34994 in Martin County. The practice phone is (772) 287-5200.

Dr. Khilnani's primary practice is Cleveland Clinic Martin North Hospital in Stuart, Florida, part of The Cleveland Clinic Foundation. Dr. Khilnani is also affiliated with Cleveland Clinic Main Campus. The medical group on file is Cleveland Clinic. Dmand AI also links Dr. Khilnani to 1 more hospital, 4 dialysis centers and 1 group practice or clinic, each named with a free account. Dr. Khilnani's employer is on file too: a hospital.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Khilnani practices, 8 sites in all. Vendor and product names are available with a free account.

Nephrology is Dr. Khilnani's primary specialty in the NPI Registry, under taxonomy code 207RN0300X. Dr. Khilnani is board certified in internal medicine by the American Board of Internal Medicine. Dmand AI has Dr. Khilnani's licenses on file in 2 states: Florida and New York.

Dmand AI lists acute kidney failure, chronic kidney disease, fluid and electrolyte imbalances, hypercalcemia, kidney cysts and kidney disease among the conditions Dr. Khilnani treats.

CMS data shows 1,196 Medicare services from Dr. Khilnani across 7 procedure codes in 2024, for 449 Medicare patients. Medicare paid $118,714 for them. Every service was in an office.

CMS counts 449 Medicare patients who saw Dr. Khilnani in 2024. The largest group is 75 to 84, with 204 patients. 75% of them have chronic kidney disease, and 75% have high blood pressure. 10% are also on Medicaid. Their average risk score is 4.00, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Khilnani's median patient age at 75, with 51% women.

In 2024, Dr. Khilnani wrote 2,857 Medicare Part D claims for 400 patients. 91% of them were for generic drugs. CMS names the drug for 2,418 of them, across 65 drugs with 11 or more claims each, at $143,497 in total drug cost. In 2023, CMS named 2,220 claims across 57 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 92 out of 100 for Dr. Khilnani for performance year 2024, reported through an alternative payment model (APM). Dr. Khilnani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Khilnani as offering telehealth.

Dmand AI links 3 papers to Dr. Khilnani in 2005. The most frequent topics are Electric Impedance, Renal Dialysis and Body Composition.

CMS Open Payments shows 50 general payments to Dr. Khilnani from 18 drug and device companies from 2016 to 2024. Food and beverage make up the largest share, 100% of the total. Relypsa, Inc. paid the most, $321.

Dmand AI lists 1 award for Dr. Khilnani, most recently CMS Stage 1 EHR in 2013.

Dr. Khilnani graduated from Krishna Institute Of Medical Sciences University in 2000.

Dr. Khilnani is in network with 10 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. Medicare plans come from the most carriers, 10. Check the plan with the practice before a visit.